Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 20.

Kulig, P; Musiol, S; Freiberger, S N; Schreiner, B; Gyülveszi, G; Russo, G; Pantelyushin, S; Kishihara, K; Alessandrini, F; Kündig, T; Sallusto, F; Hofbauer, G F L; Haak, S; Becher, B (2016). IL-12 protects from psoriasiform skin inflammation. Nature Communications, 7:13466.

Croxford, A L; Lanzinger, M; Hartmann, F J; Schreiner, B; Mair, F; Pelczar, P; Clausen, B E; Jung, S; Greter, M; Becher, B (2015). The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2(+) Monocytes and Licenses Autoimmunity. Immunity, 43(3):502-514.

Schreiner, B. Glial cell functions in CNS homeostasis and local immune regulation Zur. 2015, University of Zurich, Faculty of Medicine.

Schreiner, B; Ingold-Heppner, B; Pehl, D; Locatelli, G; Berrit-Schönthaler, H; Becher, B (2015). Deletion of Jun proteins in adult oligodendrocytes does not perturb cell survival, or myelin maintenance in vivo. PLoS ONE, 10(3):e0120454.

Locatelli, G; Baggiolini, A; Schreiner, B; Palle, P; Waisman, A; Becher, B; Buch, T (2015). Mature oligodendrocytes actively increase in vivo cytoskeletal plasticity following CNS damage. Journal of Neuroinflammation, 12:62.

Schreiner, B; Becher, B (2015). Perspectives on cytokine-directed therapies in multiple sclerosis. Swiss Medical Weekly, 145:w14199.

Kallweit, U; Jelcic, I; Braun, N; Fischer, H; Zörner, B; Schreiner, B; Sokolov, A A; Martin, R; Weller, M; Linnebank, M (2012). Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohort. Clinical Neuropharmacology, 35(2):77-80.

Schreiner, B; Heppner, F L; Becher, B (2009). Modeling multiple sclerosis in laboratory animals. Seminars in Immunopathology, 31(4):479-495.

Nowak, E C; Weaver, C T; Turner, H; Begum-Haque, S; Becher, B; Schreiner, B; Coyle, A J; Kasper, L H; Noelle, R J (2009). IL-9 as a mediator of Th17-driven inflammatory disease. Journal of Experimental Medicine, 206(8):1653-1660.

Schreiner, B; Bailey, S L; Shin, T; Chen, L; Miller, S D (2008). PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. European Journal of Immunology, 38(10):2706-2717.

Schreiner, B; Bailey, S L; Miller, S D (2007). T-cell response dynamics in animal models of multiple sclerosis: implications for immunotherapies. Expert Review of Clinical Immunology, 3(1):57-72.

Schreiner, B; Voss, J; Wischhusen, J; Dombrowski, Y; Steinle, A; Lochmüller, H; Dalakas, M; Melms, A; Wiendl, H (2006). Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. FASEB Journal, 20(1):118-120.

Schreiner, B; Kieseier, B C; Hartung, H P; Hohlfeld, R; Wiendl, H (2005). Blockade von Adhäsionsmolekülen mit Natalizumab in der Therapie der Multiplen Sklerose. Aktueller Studienstand. Der Nervenarzt, 76(8):999-1005.

Wiendl, H; Feger, U; Mittelbronn, M; Jack, C; Schreiner, B; Stadelmann, C; Antel, J; Brueck, W; Meyermann, R; Bar-Or, A; Kieseier, B C; Weller, M (2005). Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain: A Journal of Neurology, 128(Pt 11):2689-2704.

Magnus, T; Schreiner, B; Korn, T; Jack, C; Guo, H; Antel, J; Ifergan, I; Chen, L; Bischof, F; Bar-Or, A; Wiendl, H (2005). Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. Journal of Neuroscience, 25(10):2537-2546.

Mitsdoerffer, M; Schreiner, B; Kieseier, B C; Neuhaus, O; Dichgans, J; Hartung, H P; Weller, M; Wiendl, H (2005). Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. Journal of Neuroimmunology, 159(1-2):155-164.

Schreiner, B; Mitsdoerffer, M; Kieseier, B C; Chen, L; Hartung, H P; Weller, M; Wiendl, H (2004). Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Journal of Neuroimmunology, 155(1-2):172-182.

Weissert, R; Wiendl, H; Pfrommer, H; Storch, M K; Schreiner, B; Barth, S; Seifert, T; Melms, A; Dichgans, J; Weller, M (2003). Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes. Journal of Neuroimmunology, 144(1-2):28-37.

Wintterle, S; Schreiner, B; Mitsdoerffer, M; Schneider, D; Chen, L; Meyermann, R; Weller, M; Wiendl, H (2003). Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Research, 63(21):7462-7467.

Schreiner, B; Wischhusen, J; Mitsdoerffer, M; Schneider, D; Bornemann, A; Melms, A; Tolosa, E; Weller, M; Wiendl, H (2003). Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo. Glia, 44(3):296-301.

This list was generated on Tue Oct 17 12:51:10 2017 CEST.